LiveVox Announces Second Quarter 2022 Financial Results
LiveVox Holdings reported a strong financial performance for Q2 2022, with total revenue rising 14.1% to $33.0 million and contract revenue up 19.7% to $26.8 million. The company's gross profit increased by 180.1% to $20.4 million. However, LiveVox still faced a net loss of $10.8 million, though this was significantly reduced from $75.8 million in Q2 2021. Adjusted EBITDA losses also widened to $5.6 million from $2.6 million in the previous year. The outlook remains cautious amid economic uncertainties, particularly with COVID-19.
- Total revenue increased by 14.1% year-over-year to $33.0 million.
- Contract revenue saw a significant growth of 19.7% year-over-year, reaching $26.8 million.
- Gross profit surged by 180.1% compared to the same quarter last year.
- The company emphasized a shift to 100% public cloud, improving performance.
- Net loss of $10.8 million, although improved from $75.8 million in Q2 2021.
- Adjusted EBITDA loss grew to $5.6 million from $2.6 million year-over-year.
- Weak excess usage revenue noted during the quarter.
Second quarter contract revenue year-over-year growth of
Second quarter total revenue year-over-year growth of
“Our Adjusted EBITDA performance came in above the high end of guidance and remains significantly ahead of schedule. We will be Adjusted EBITDA positive in Q4 of 2022, pivoting
Second Quarter 2022 Financial Highlights
-
Revenue: Total revenue was
for the second quarter of 2022, up$33.0 million 14.1% compared to for the second quarter of 2021.$28.9 million -
Contract Revenue: Contract revenue was
for the second quarter of 2022, up$26.8 million 19.7% compared to for the second quarter of 2021.$22.4 million -
Gross Profit: Gross profit was
for the second quarter of 2022, up$20.4 million 180.1% compared to for the second quarter of 2021.$7.3 million -
Non-GAAP Gross Profit* and Non-GAAP Gross Margin*: Non-GAAP gross profit was
for the second quarter of 2022, up$21.2 million 18.7% compared to for the second quarter of 2021; Non-GAAP gross margin was$17.8 million 64.2% for the second quarter of 2022 after adjusting for stock-based compensation associated with restricted stock units and performance-based restricted stock units granted under the 2021 Equity Incentive Plan and depreciation and amortization, compared to61.7% for the second quarter of 2021. -
Net loss: Net loss was
for the second quarter of 2022, compared to net loss of$10.8 million for the second quarter of 2021.$75.8 million -
Adjusted EBITDA*: Adjusted EBITDA loss was
for the second quarter of 2022, compared to Adjusted EBITDA loss of$5.6 million for the second quarter of 2021.$2.6 million
* Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Business Outlook
In determining the financial guidance to provide to investors, the Company considered its recent business trends and financial results, current growth plans, strategic initiatives, global economic outlook and the continued uncertainty of COVID-19 and its potential impact on the Company’s results.
-
Third Quarter of 2022 Guidance:
-
Total revenue is expected to be in the range of
to$35.0 million , representing growth of$36.0 million 15% to18% year-over-year. -
Contract revenue is expected to be in the range of
to$27.5 million , representing growth of$28.0 million 19% to21% year-over-year. -
Excess usage revenue is expected to be in the range of
to$7.5 million , representing growth of$8.0 million 1% to7% year-over-year. -
Adjusted EBITDA loss is expected to be in the range of
to$3.6 million .$2.6 million
-
Total revenue is expected to be in the range of
-
Full Year 2022 Guidance:
-
Total revenue is expected to be in the range of
to$138 million , representing growth of$140 million 16% to17% year-over-year. -
Contract revenue is expected to be in the range of
to$108 million , representing growth of$109 million 19% to20% year-over-year. -
Excess usage revenue is expected to be in the range of
to$28 million , representing growth of (3)% to$31 million 8% year-over-year. -
Adjusted EBITDA loss is now expected to be in the range of
to$17 million .$15 million
-
Total revenue is expected to be in the range of
Quarterly Conference Call
About
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements relating to expected bookings, expected revenue and annual recurring revenue from contracts, growth expectations, and future financial results, including guidance. These statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LiveVox’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Any such forward-looking statements are made pursuant to the safe harbor provisions available under applicable securities laws and speak only as of the date of this presentation.
Important factors, among others, that may affect actual results or outcomes include risks or liabilities assumed as a result of our ability to meet financial and operating guidance, ability to achieve financial targets, and successfully manage capital expenditures; risks related to the high level of competition in the cloud contact center industry and the intense competition and competitive pressures from other companies in the industry in which the Company operates; risks related to the Company’s reliance on information systems and the ability to properly maintain the confidentiality and integrity of data; risks related to the occurrence of cyber incidents or a deficiency in cybersecurity protocols; risks related to the ability to obtain third-party software licenses for use in or with the Company’s products; general economic and business conditions; the impact of COVID-19 on LiveVox’s business; risks related to our intellectual property rights, risks related to our ability to secure additional financing on favorable terms, or at all, to meet our capital needs; increased taxes and surcharges (including
The information contained in this press release is summary information that is intended to be considered in the context of LiveVox’s
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (In thousands, except per share data) |
|||||||||||||||
|
For the three months ended
|
|
For the six months ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue |
$ |
32,987 |
|
|
$ |
28,913 |
|
|
$ |
65,080 |
|
|
$ |
56,858 |
|
Cost of revenue |
|
12,548 |
|
|
|
21,615 |
|
|
|
26,180 |
|
|
|
32,795 |
|
Gross profit |
|
20,439 |
|
|
|
7,298 |
|
|
|
38,900 |
|
|
|
24,063 |
|
Operating expenses |
|
|
|
|
|
|
|
||||||||
Sales and marketing expense |
|
14,970 |
|
|
|
27,685 |
|
|
|
29,622 |
|
|
|
36,593 |
|
General and administrative expense |
|
7,546 |
|
|
|
24,637 |
|
|
|
15,014 |
|
|
|
29,517 |
|
Research and development expense |
|
8,167 |
|
|
|
30,169 |
|
|
|
16,657 |
|
|
|
36,349 |
|
Total operating expenses |
|
30,683 |
|
|
|
82,491 |
|
|
|
61,293 |
|
|
|
102,459 |
|
Loss from operations |
|
(10,244 |
) |
|
|
(75,193 |
) |
|
|
(22,393 |
) |
|
|
(78,396 |
) |
Interest expense, net |
|
744 |
|
|
|
941 |
|
|
|
1,494 |
|
|
|
1,885 |
|
Change in the fair value of warrant liability |
|
(92 |
) |
|
|
(375 |
) |
|
|
(484 |
) |
|
|
(375 |
) |
Other expense, net |
|
113 |
|
|
|
32 |
|
|
|
49 |
|
|
|
25 |
|
Total other expense, net |
|
765 |
|
|
|
598 |
|
|
|
1,059 |
|
|
|
1,535 |
|
Pre-tax loss |
|
(11,009 |
) |
|
|
(75,791 |
) |
|
|
(23,452 |
) |
|
|
(79,931 |
) |
Provision for (benefit from) income taxes |
|
(229 |
) |
|
|
52 |
|
|
|
315 |
|
|
|
87 |
|
Net loss |
$ |
(10,780 |
) |
|
$ |
(75,843 |
) |
|
$ |
(23,767 |
) |
|
$ |
(80,018 |
) |
Comprehensive loss |
|
|
|
|
|
|
|
||||||||
Net loss |
$ |
(10,780 |
) |
|
$ |
(75,843 |
) |
|
$ |
(23,767 |
) |
|
$ |
(80,018 |
) |
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment |
|
(153 |
) |
|
|
(25 |
) |
|
|
(202 |
) |
|
|
14 |
|
Net unrealized loss on marketable securities |
|
(288 |
) |
|
|
— |
|
|
|
(1,176 |
) |
|
|
— |
|
Total other comprehensive income (loss), net of tax |
|
(441 |
) |
|
|
(25 |
) |
|
|
(1,378 |
) |
|
|
14 |
|
Comprehensive loss |
$ |
(11,221 |
) |
|
$ |
(75,868 |
) |
|
$ |
(25,145 |
) |
|
$ |
(80,004 |
) |
Net loss per share |
|
|
|
|
|
|
|
||||||||
Net loss per share—basic and diluted |
$ |
(0.12 |
) |
|
$ |
(1.08 |
) |
|
$ |
(0.26 |
) |
|
$ |
(1.17 |
) |
Weighted average shares outstanding—basic and diluted |
|
91,562 |
|
|
|
69,945 |
|
|
|
91,520 |
|
|
|
68,291 |
|
Consolidated Balance Sheets (In thousands, except per share data) |
|||||||
|
As of |
||||||
|
|
|
|
||||
|
(Unaudited) |
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
29,873 |
|
|
$ |
47,217 |
|
Restricted cash, current |
|
100 |
|
|
|
100 |
|
Marketable securities, current |
|
47,220 |
|
|
|
7,226 |
|
Accounts receivable, net |
|
18,524 |
|
|
|
20,128 |
|
Deferred sales commissions, current |
|
2,885 |
|
|
|
2,691 |
|
Prepaid expenses and other current assets |
|
4,068 |
|
|
|
6,151 |
|
Total Current Assets |
|
102,670 |
|
|
|
83,513 |
|
Property and equipment, net |
|
3,207 |
|
|
|
3,010 |
|
|
|
47,481 |
|
|
|
47,481 |
|
Intangible assets, net |
|
18,320 |
|
|
|
20,195 |
|
Operating lease right-of-use assets |
|
5,221 |
|
|
|
5,483 |
|
Deposits and other |
|
406 |
|
|
|
664 |
|
Marketable securities, net of current |
|
— |
|
|
|
42,148 |
|
Deferred sales commissions, net of current |
|
6,965 |
|
|
|
6,747 |
|
Deferred tax asset, net |
|
89 |
|
|
|
— |
|
Total Assets |
$ |
184,359 |
|
|
$ |
209,241 |
|
|
|
|
|
||||
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
6,081 |
|
|
$ |
6,490 |
|
Accrued expenses |
|
10,208 |
|
|
|
13,855 |
|
Deferred revenue, current |
|
1,142 |
|
|
|
1,307 |
|
Term loan, current |
|
701 |
|
|
|
561 |
|
Operating lease liabilities, current |
|
1,890 |
|
|
|
1,946 |
|
Finance lease liabilities, current |
|
25 |
|
|
|
26 |
|
Total current liabilities |
|
20,047 |
|
|
|
24,185 |
|
Long term liabilities: |
|
|
|
||||
Deferred revenue, net of current |
|
452 |
|
|
|
456 |
|
Term loan, net of current |
|
54,092 |
|
|
|
54,459 |
|
Operating lease liabilities, net of current |
|
3,729 |
|
|
|
4,046 |
|
Finance lease liabilities, net of current |
|
— |
|
|
|
11 |
|
Deferred tax liability, net |
|
— |
|
|
|
2 |
|
Warrant liability |
|
283 |
|
|
|
767 |
|
Other long-term liabilities |
|
338 |
|
|
|
337 |
|
Total liabilities |
|
78,941 |
|
|
|
84,263 |
|
|
|
|
|
||||
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Preferred stock, |
|
— |
|
|
|
— |
|
Common stock, |
|
9 |
|
|
|
9 |
|
Additional paid-in capital |
|
259,053 |
|
|
|
253,468 |
|
Accumulated other comprehensive loss |
|
(1,855 |
) |
|
|
(477 |
) |
Accumulated deficit |
|
(151,789 |
) |
|
|
(128,022 |
) |
Total stockholders’ equity |
|
105,418 |
|
|
|
124,978 |
|
Total liabilities & stockholders’ equity |
$ |
184,359 |
|
|
$ |
209,241 |
|
Consolidated Statements of Cash Flows (Unaudited) (Dollars in thousands) |
|||||||
|
For the six months ended June
|
||||||
|
|
2022 |
|
|
|
2021 |
|
Operating activities: |
|
|
|
||||
Net loss |
$ |
(23,767 |
) |
|
$ |
(80,018 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
556 |
|
|
|
962 |
|
Amortization of identified intangible assets |
|
1,875 |
|
|
|
2,244 |
|
Amortization of deferred loan origination costs |
|
54 |
|
|
|
72 |
|
Amortization of deferred sales commissions |
|
1,507 |
|
|
|
832 |
|
Non-cash lease expense |
|
931 |
|
|
|
801 |
|
Stock-based compensation expense |
|
5,902 |
|
|
|
278 |
|
Equity incentive bonus |
|
— |
|
|
|
68,674 |
|
Bad debt expense |
|
402 |
|
|
|
22 |
|
Deferred income tax benefit |
|
(91 |
) |
|
|
(230 |
) |
Loss on sale of marketable securities |
|
42 |
|
|
|
— |
|
Amortization of premium paid on marketable securities |
|
246 |
|
|
|
— |
|
Change in the fair value of the warrant liability |
|
(484 |
) |
|
|
(375 |
) |
Offering cost associated with Warrants recorded as liabilities |
|
— |
|
|
|
41 |
|
Changes in assets and liabilities |
|
|
|
||||
Accounts receivable |
|
1,203 |
|
|
|
(1,358 |
) |
Other assets |
|
2,340 |
|
|
|
(807 |
) |
Deferred sales commissions |
|
(1,919 |
) |
|
|
(1,609 |
) |
Accounts payable |
|
(409 |
) |
|
|
1,362 |
|
Accrued expenses |
|
(3,647 |
) |
|
|
218 |
|
Deferred revenue |
|
(169 |
) |
|
|
(33 |
) |
Operating lease liabilities |
|
(990 |
) |
|
|
(724 |
) |
Other long-term liabilities |
|
— |
|
|
|
(1 |
) |
Net cash used in operating activities |
|
(16,418 |
) |
|
|
(9,649 |
) |
Investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(772 |
) |
|
|
(604 |
) |
Purchases of marketable securities |
|
(5,413 |
) |
|
|
— |
|
Proceeds from sale of marketable securities |
|
3,451 |
|
|
|
— |
|
Proceeds from maturities and principal paydowns of marketable securities |
|
2,652 |
|
|
|
— |
|
Proceeds from asset acquisition, net of cash paid |
|
— |
|
|
|
1,326 |
|
Net cash provided by (used in) investing activities |
|
(82 |
) |
|
|
722 |
|
Financing activities: |
|
|
|
||||
Proceeds from Merger and PIPE financing, net of cash paid |
|
— |
|
|
|
157,383 |
|
Repayment on loan payable |
|
(280 |
) |
|
|
(1,536 |
) |
Repayment of drawdown on line of credit |
|
— |
|
|
|
(4,672 |
) |
Repayments on finance lease obligations |
|
(13 |
) |
|
|
(242 |
) |
Payment of employees’ withholding taxes on net share settlement of share-based awards |
|
(317 |
) |
|
|
— |
|
Net cash provided by (used in) financing activities |
|
(610 |
) |
|
|
150,933 |
|
Effect of foreign currency translation |
|
(234 |
) |
|
|
(49 |
) |
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
(17,344 |
) |
|
|
141,957 |
|
Cash, cash equivalents, and restricted cash beginning of period |
|
47,317 |
|
|
|
19,566 |
|
Cash, cash equivalents, and restricted cash end of period |
$ |
29,973 |
|
|
$ |
161,523 |
|
|
|
|
|
|
For the six months ended |
||||
|
2022 |
|
2021 |
||
Supplemental disclosure of cash flow information: |
|
|
|
||
Interest paid |
$ |
1,626 |
|
$ |
1,805 |
Income taxes paid |
|
247 |
|
|
175 |
Supplemental schedule of noncash investing activities: |
|
|
|
||
Change in unrealized loss on marketable securities |
$ |
1,177 |
|
$ |
— |
Additional right-of-use assets |
|
617 |
|
|
3,246 |
Contingent consideration in asset acquisition |
|
— |
|
|
7,000 |
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets (dollars in thousands):
|
As of |
||||
|
|
2022 |
|
|
2021 |
Cash and cash equivalents |
$ |
29,873 |
|
$ |
161,423 |
Restricted cash, current |
|
100 |
|
|
— |
Restricted cash, net of current |
|
— |
|
|
100 |
Total cash, cash equivalents and restricted cash |
$ |
29,973 |
|
$ |
161,523 |
Non-GAAP Financial Measures
Management uses non-GAAP financial measures to evaluate operating performance. We believe non-GAAP financial measures provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors.
Adjusted EBITDA
We monitor Adjusted EBITDA, a non-generally accepted accounting principle (“Non-GAAP”) financial measure, to analyze our financial results and believe that it is useful to investors, as a supplement to
Non-GAAP Gross Profit and Non-GAAP Gross Margin Percentage
Management uses Non-GAAP gross profit and Non-GAAP gross margin percentage to evaluate operating performance and to determine resource allocation among our various product offerings. We believe Non-GAAP gross profit and Non-GAAP gross margin percentage provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors. Non-GAAP gross profit and Non-GAAP gross margin percentage may not be comparable to similarly titled measures of other companies because other companies may not calculate Non-GAAP gross profit and Non-GAAP gross margin percentage or similarly titled measures in the same manner as we do.
Please see tables below for a reconciliation of non-GAAP measures to the most directly comparable GAAP measures for the periods presented.
GAAP Net Loss to Adjusted EBITDA (Unaudited) (Dollars in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net loss |
$ |
(10,780 |
) |
|
$ |
(75,843 |
) |
|
$ |
(23,767 |
) |
|
$ |
(80,018 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
1,085 |
|
|
|
1,602 |
|
|
|
2,431 |
|
|
|
3,205 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
3,423 |
|
|
|
69,423 |
|
|
|
5,902 |
|
|
|
69,965 |
|
Interest expense, net |
|
744 |
|
|
|
941 |
|
|
|
1,494 |
|
|
|
1,885 |
|
Change in the fair value of warrant liability |
|
(92 |
) |
|
|
(375 |
) |
|
|
(484 |
) |
|
|
(375 |
) |
Other expense, net |
|
113 |
|
|
|
32 |
|
|
|
49 |
|
|
|
25 |
|
Acquisition and financing related fees and expenses |
|
— |
|
|
|
1,041 |
|
|
|
— |
|
|
|
1,041 |
|
Transaction-related costs |
|
183 |
|
|
|
570 |
|
|
|
183 |
|
|
|
1,303 |
|
|
|
— |
|
|
|
(25 |
) |
|
|
— |
|
|
|
146 |
|
Provision for (benefit from) income taxes |
|
(229 |
) |
|
|
51 |
|
|
|
315 |
|
|
|
86 |
|
Adjusted EBITDA |
$ |
(5,553 |
) |
|
$ |
(2,583 |
) |
|
$ |
(13,877 |
) |
|
$ |
(2,737 |
) |
GAAP Gross Profit to Non-GAAP Gross Profit (Unaudited) (Dollars in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Gross profit |
$ |
20,439 |
|
|
$ |
7,298 |
|
|
$ |
38,900 |
|
|
$ |
24,063 |
|
Depreciation and amortization |
|
342 |
|
|
|
911 |
|
|
|
952 |
|
|
|
1,858 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
403 |
|
|
|
9,633 |
|
|
|
715 |
|
|
|
9,686 |
|
Non-GAAP gross profit |
$ |
21,184 |
|
|
$ |
17,842 |
|
|
$ |
40,567 |
|
|
$ |
35,607 |
|
|
|
|
|
|
|
|
|
||||||||
Gross margin % |
|
62.0 |
% |
|
|
25.2 |
% |
|
|
59.8 |
% |
|
|
42.3 |
% |
Non-GAAP gross margin % |
|
64.2 |
% |
|
|
61.7 |
% |
|
|
62.3 |
% |
|
|
62.6 |
% |
The following table presents the stock-based compensation expenses included in Company’s results of operations for the three and six months ended
|
Three Months Ended
|
|
Six Months Ended |
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenue |
$ |
403 |
|
$ |
14 |
|
$ |
715 |
|
$ |
28 |
Sales and marketing expense |
|
870 |
|
|
28 |
|
|
1,477 |
|
|
56 |
General and administrative expense |
|
941 |
|
|
69 |
|
|
1,601 |
|
|
138 |
Research and development expense |
|
1,209 |
|
|
28 |
|
|
2,109 |
|
|
56 |
Total stock-based compensation |
$ |
3,423 |
|
$ |
139 |
|
$ |
5,902 |
|
$ |
278 |
The following table presents the long-term equity incentive bonus included in Company’s results of operations for the three and six months ended
|
Three Months Ended
|
|
Six Months Ended |
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenue |
$ |
— |
|
$ |
9,619 |
|
$ |
— |
|
$ |
9,658 |
Sales and marketing expense |
|
— |
|
|
17,964 |
|
|
— |
|
|
18,087 |
General and administrative expense |
|
— |
|
|
18,307 |
|
|
— |
|
|
18,401 |
Research and development expense |
|
— |
|
|
23,394 |
|
|
— |
|
|
23,541 |
Total long-term equity incentive bonus |
$ |
— |
|
$ |
69,284 |
|
$ |
— |
|
$ |
69,687 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005939/en/
Investor Contacts:
awaadt@livevox.com
livevoxIR@icrinc.com
Press contacts:
nbandy@livevox.com
livevoxPR@icrinc.com
Source:
FAQ
What were LiveVox's revenue figures for Q2 2022?
How did LiveVox's contract revenue perform in Q2 2022?
What was LiveVox's net loss for the second quarter of 2022?